D. Emma

The fusion of erythrocytes by treatment with proteolytic enzymes and polyethylene glycol.

J. Galla, O. Gamborg, J. Hartmann, 1976, Canadian journal of genetics and cytology. Journal canadien de genetique et de cytologie.

Residual adriamycin (AdR)-induced hematopoietic damage: a consideration for subsequent radiotherapy.

M. Evans, C. Scarantino, C. Kovacs, 1985, International journal of radiation oncology, biology, physics.

Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro.

J. Yannelli, R. Birch, S. Dupere, 1990, Journal of biological response modifiers.

Haemopoietic modulation in tumour‐bearing animals: enhanced progenitor‐cell production in femoral marrow

C. Scarantino, M. J. Evans, C. Kovacs, 1985, Cell and tissue kinetics.

Enhancement of colony-stimulating activity (CSA) on murine CFU-gm by the H-4-II-E2 (H4) tumor cell line of the rat.

M. J. Evans, C. Kovacs, R. Johnke, 1984, International journal of cell cloning.

Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors.

M. Evans, C. Kovacs, R. Johnke, 1986, Experimental hematology.

Levamisole meets sulfhydryl requirements of CTLL-2 cells and mediates enhanced proliferative response to mitogen stimulation without increasing interleukin-2 production.

S. Pruett, S. Dupere, N. Obiri, 1990, Journal of biological response modifiers.